• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图与非酒精性脂肪性肝病

Echocardiography and NAFLD (non-alcoholic fatty liver disease).

作者信息

Trovato Francesca M, Martines Giuseppe F, Catalano Daniela, Musumeci Giuseppe, Pirri Clara, Trovato Guglielmo M

机构信息

University of Catania, School of Medicine, Department of Clinical and Experimental Medicine, Catania, Italy.

University of Catania, School of Medicine, Department of Biomedical and Biotechnological Sciences, Human Anatomy and Histology section, Catania, Italy.

出版信息

Int J Cardiol. 2016 Oct 15;221:275-9. doi: 10.1016/j.ijcard.2016.06.180. Epub 2016 Jun 29.

DOI:10.1016/j.ijcard.2016.06.180
PMID:27404689
Abstract

UNLABELLED

Non-alcoholic-fatty-liver-disease (NAFLD) is associated with atherosclerosis, increased cardiovascular risks and mortality. We investigated if, independently of insulin resistance, diet, physical activity and obesity, fatty liver involvement has any relationship with echocardiographic measurements in NAFLD.

PATIENTS AND METHODS

660 NAFLD and 791 non-NAFLD subjects, referred to the same out-patients medical unit for lifestyle-nutritional prescription, were studied. Congestive heart failure, myocardial infarction, malignancies, diabetes mellitus, extreme obesity, underweight-bad-nourished subjects and renal insufficiency were exclusion criteria. Liver steatosis was assessed by Ultrasound-Bright-Liver-Score (BLS), left ventricular ejection fraction (LVEF), trans-mitral E/A doppler ratio (diastolic relaxation) and left ventricular myocardial mass (LVMM/m(2)) by echocardiography. Doppler Renal artery Resistive Index (RRI), insulin resistance (HOMA) and lifestyle profile were also included in the clinical assessment.

RESULTS

LVMM/m(2) is significantly greater in NAFLD, 101.62±34.48 vs. 88.22±25.61, p<0.0001 both in men and in women. Ejection fraction is slightly smaller only in men with NAFLD; no significant difference was observed for the E/A ratio. BMI (30.42±5.49 vs. 24.87±3.81; p<0.0001) and HOMA (2.90±1.70 vs. 1.85±1.25; p: 0.0001) were significantly greater in NAFLD patients. By Multiple-Linear-Regression, NAFLD and unhealthy dietary profile are associated also in lean non-diabetic subjects with lower systolic function, independently of BMI, dietary profile, physical activity, RRI and insulin resistance.

CONCLUSION

NAFLD may be a meaningful early clue suggestive of diminishing heart function, with similar determining factors. NAFLD is amenable to management and improvement by lifestyle change counseling, addressing a dual target: reducing fatty liver, which is easily monitored by ultrasound, and, independently, maintaining a normal heart function.

摘要

未标注

非酒精性脂肪性肝病(NAFLD)与动脉粥样硬化、心血管风险增加及死亡率相关。我们研究了在不考虑胰岛素抵抗、饮食、体力活动和肥胖的情况下,NAFLD中的脂肪肝累及情况与超声心动图测量值之间是否存在任何关联。

患者与方法

对660例NAFLD患者和791例非NAFLD患者进行了研究,这些患者因生活方式 - 营养处方被转诊至同一门诊医疗单元。充血性心力衰竭、心肌梗死、恶性肿瘤、糖尿病、极度肥胖、体重过轻 - 营养不良的患者以及肾功能不全患者为排除标准。通过超声 - 肝脏明亮评分(BLS)评估肝脏脂肪变性,通过超声心动图评估左心室射血分数(LVEF)、二尖瓣E/A多普勒比值(舒张期松弛)和左心室心肌质量(LVMM/m²)。临床评估还包括多普勒肾动脉阻力指数(RRI)、胰岛素抵抗(HOMA)和生活方式概况。

结果

NAFLD患者的LVMM/m²显著更高,男性为101.62±34.48,女性为88.22±25.61,男性和女性的p值均<0.0001。仅男性NAFLD患者的射血分数略低;E/A比值未观察到显著差异。NAFLD患者的BMI(30.42±5.49 vs. 24.87±3.81;p<0.0001)和HOMA(2.90±1.70 vs. 1.85±1.25;p:0.0001)显著更高。通过多元线性回归分析,在收缩功能较低的瘦型非糖尿病受试者中,NAFLD与不健康的饮食模式也相关,且不受BMI、饮食模式、体力活动、RRI和胰岛素抵抗的影响。

结论

NAFLD可能是提示心脏功能减退的一个有意义的早期线索,且有相似的决定因素。NAFLD可通过生活方式改变咨询进行管理和改善,实现双重目标:减少脂肪肝(可通过超声轻松监测),并独立维持正常心脏功能。

相似文献

1
Echocardiography and NAFLD (non-alcoholic fatty liver disease).超声心动图与非酒精性脂肪性肝病
Int J Cardiol. 2016 Oct 15;221:275-9. doi: 10.1016/j.ijcard.2016.06.180. Epub 2016 Jun 29.
2
Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.地中海饮食和体育活动结合咨询支持疗法对非酒精性脂肪性肝病严重程度的影响。
World J Gastroenterol. 2017 May 7;23(17):3150-3162. doi: 10.3748/wjg.v23.i17.3150.
3
Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.地中海饮食与非酒精性脂肪性肝病:需要扩展和综合干预。
Clin Nutr. 2015 Feb;34(1):86-8. doi: 10.1016/j.clnu.2014.01.018. Epub 2014 Jan 31.
4
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.非酒精性脂肪性肝炎与非肝硬化患者亚临床心肌功能障碍的相关性。
J Hepatol. 2018 Apr;68(4):764-772. doi: 10.1016/j.jhep.2017.11.023. Epub 2017 Nov 24.
5
Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.青少年的脂肪肝疾病与生活方式:饮食、食物摄入频率、运动、睡眠不足及时尚
Liver Int. 2016 Mar;36(3):427-33. doi: 10.1111/liv.12957. Epub 2015 Sep 28.
6
Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.非酒精性脂肪性肝病(NAFLD)患者的肝动脉阻力指数(HARI)与非酒精性脂肪性肝病纤维化评分:提示非酒精性脂肪性肝炎(NASH)进展的临界值
J Ultrasound. 2016 Mar 29;19(3):183-9. doi: 10.1007/s40477-016-0203-8. eCollection 2016 Sep.
7
Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.坚持地中海饮食与非酒精性脂肪性肝病:对胰岛素抵抗的影响。
Am J Gastroenterol. 2017 Dec;112(12):1832-1839. doi: 10.1038/ajg.2017.371. Epub 2017 Oct 24.
8
Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study.非酒精性脂肪肝疾病与心肌结构和功能变化的纵向关联:CARDIA 研究。
J Am Heart Assoc. 2020 Feb 18;9(4):e014279. doi: 10.1161/JAHA.119.014279. Epub 2020 Feb 6.
9
Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.非酒精性脂肪性肝炎与 2 型糖尿病患者左心室舒张功能障碍的相关性。
Diabetes Metab J. 2020 Apr;44(2):267-276. doi: 10.4093/dmj.2019.0001. Epub 2019 Feb 28.
10
Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.非酒精性脂肪性肝病肥胖儿童和青少年的左心室功能障碍。
Hepatology. 2014 Feb;59(2):461-70. doi: 10.1002/hep.26610. Epub 2013 Dec 23.

引用本文的文献

1
Decreased liver-to-spleen ratio in low-dose computed tomography as a biomarker of fatty liver disease reflects risk for myocardial ischaemia.低剂量计算机断层扫描中肝脏与脾脏比值降低作为脂肪肝疾病的生物标志物反映了心肌缺血风险。
Eur Heart J Imaging Methods Pract. 2023 Aug 10;1(1):qyad016. doi: 10.1093/ehjimp/qyad016. eCollection 2023 May.
2
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis.代谢功能障碍相关脂肪性肝病(MASLD)与肝硬化住院患者充血性心力衰竭风险增加的关联:一项倾向评分匹配分析
Cureus. 2024 Jun 15;16(6):e62441. doi: 10.7759/cureus.62441. eCollection 2024 Jun.
3
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk.代谢相关脂肪性肝病(MAFLD)发病机制的新见解:肠-肝-心轴的相互作用
Nutrients. 2023 Sep 14;15(18):3970. doi: 10.3390/nu15183970.
4
Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study.弗雷明汉脂肪肝指数对心血管风险的预测价值:一项基于全国人群的队列研究。
Front Cardiovasc Med. 2023 Jul 18;10:1163052. doi: 10.3389/fcvm.2023.1163052. eCollection 2023.
5
Nonalcoholic fatty liver disease and non-liver comorbidities.非酒精性脂肪性肝病与非肝脏合并症。
Clin Mol Hepatol. 2023 Feb;29(Suppl):s86-s102. doi: 10.3350/cmh.2022.0442. Epub 2023 Jan 5.
6
Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension.未经治疗的单纯性高血压患者中非酒精性脂肪性肝病与左心室改变的关联
Front Cardiovasc Med. 2022 Oct 13;9:1030968. doi: 10.3389/fcvm.2022.1030968. eCollection 2022.
7
Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective.心脏病与代谢性脂肪变性之间的相互作用:当代视角
J Clin Med. 2021 Apr 8;10(8):1569. doi: 10.3390/jcm10081569.
8
Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management.非酒精性脂肪性肝炎中的心血管疾病:筛查与管理
Curr Hepatol Rep. 2020 Sep;19(3):315-326. doi: 10.1007/s11901-020-00530-0. Epub 2020 Jun 29.
9
NAFLD and cardiovascular diseases: a clinical review.非酒精性脂肪性肝病与心血管疾病:临床综述。
Clin Res Cardiol. 2021 Jul;110(7):921-937. doi: 10.1007/s00392-020-01709-7. Epub 2020 Jul 21.
10
The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study.非酒精性脂肪性肝病与心脏结构和功能的关联——弗雷明汉心脏研究
Liver Int. 2020 Oct;40(10):2445-2454. doi: 10.1111/liv.14600. Epub 2020 Jul 25.